Jacques A. J. Malherbe

Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms

Jacques A. J. Malherbe, Kathryn A. Fuller, Ayesha Arshad et al. · Journal of Clinical Pathology · 2015 · 30 citations · Full text

Medicine, Hematology, Molecular Biology +15

Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis

Belinda B. Guo, Matthew D. Linden, Kathryn A. Fuller et al. · British Journal of Haematology · 2019 · 25 citations · Full text

Medicine, Hematology, Pathology +14

Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations

Belinda B. Guo, Richard J. N. Allcock, Bob Mirzai et al. · American Journal Of Pathology · 2017 · 18 citations · Full text

Veterinary Medicine, Cell Biology, Molecular Genetics +10

BJS commission on surgery and perioperative care post-COVID-19

Egide Abahuje, Aya Abbas, Mohamed A. Maksoud et al. · British journal of surgery · 2021 · 17 citations · Full text

Medicine, Perioperative Medicine, Surgery +16

Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms

Jacques A. J. Malherbe, Kathryn A. Fuller, Bob Mirzai et al. · Journal of Clinical Pathology · 2016 · 12 citations · Full text

Life Sciences, Cell Biology, Hematology +17